Evaluation of immune-checkpoint molecules in dMMR/pMMR colorectal cancer by multiplex immunohistochemistry
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03691-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Sergei Sergeevich Naumov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Siberian State Medical University, Tomsk, 634050, Russia. serg.nau2011@gmail.com. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Immune Checkpoint Proteins. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Siberian State Medical University, Tomsk, 634050, Russia. serg.nau2011@gmail.com.
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences , Tomsk, 634009, Russia.
- Siberian State Medical University, Tomsk, 634050, Russia.
Zitieren
APA
Naumov, S. S., Tashireva, L. A., Krakhmal, N. V., & Vtorushin, S. V. (2024). Evaluation of immune-checkpoint molecules in dMMR/pMMR colorectal cancer by multiplex immunohistochemistry. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03691-2
Vancouver
Naumov SS, Tashireva LA, Krakhmal NV, Vtorushin SV. Evaluation of immune-checkpoint molecules in dMMR/pMMR colorectal cancer by multiplex immunohistochemistry. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03691-2
BibTeX
@article{Naumov2024,
author = {Naumov, Sergei Sergeevich and Tashireva, Liubov Alexandrovna and Krakhmal, Nadezhda Valerievna and Vtorushin, Sergey Vladimirovich},
title = {Evaluation of immune-checkpoint molecules in dMMR/pMMR colorectal cancer by multiplex immunohistochemistry},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03691-2}
}
EUVIMED